Outlook Therapeutics's total assets for Q1 2025 were $17.01T, an increase of 59001302.14% from the previous quarter. OTLK total liabilities were $67.30T for the fiscal quarter, a 66041824.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.